LSI 2026 – Showcasing Innovation
At LSI 2026, Fallouh Healthcare Limited showcased its latest innovations, highlighting our newest advancements and strategic vision. We engaged with […]
Fallouh Healthcare’s device to give early diagnosis for post-surgery strangulation risk
U.K.-based Fallouh Healthcare is developing a device to monitor cardiac patients after surgery, which is when a condition, called cardiac
New device provides early diagnosis for cardiac tamponade
Patients recovering from heart surgery can be at risk from a life-threatening condition where fluid builds up around the heart,
New device from Birmingham, U.K., to provide early diagnosis for cardiac tamponade
Diagnostic device to monitor against post-surgery heart strangulation risk under development by company formed by Birmingham cardiothoracic surgeon Patients recovering
Recognised for Excellence in Surgical Innovation by the European association for cardiothoracic surgery
Dr. Hazem Fallouh, founder of Fallouh Healthcare, has been internationally recognised for his contributions to cardiothoracic surgery. He was awarded
Early Innovation Backed by WMHTIA: Laying the Foundations for PerDeCT
In 2024, Fallouh Healthcare was awarded a £50,000 grant from the West Midlands Health Technologies Innovation Accelerator (WMHTIA) — a
Where Clinical Need Meets Innovation: A £500K Step Toward Safer Cardiac Surgery
A Pivotal Step in Advancing PerDeCT Fallouh Healthcare was awarded a £500,000 grant from Innovate UK, the UK’s national innovation
Eurostars Grant Secured for PerDeCT Preclinical Trials
Fallouh Healthcare is proud to announce it has secured €900,000 in funding through the prestigious Eurostars 3 programme, part of